Skip to main content
. 2021 Oct 8;27(5):1911–1923. doi: 10.1007/s10741-021-10177-8

Fig. 4.

Fig. 4

Time course of cardiac changes following treatment with elamipretide [56]. Chronic therapy with elamipretide, which selectively targets abnormal mitochondrial function of the failing heart, can ultimately lead to durable functional and structural improvements of the left ventricle as a whole. Used with permission [56]